Advancing Human Vaccine Development Using Humanized Mouse Models
Open Access
Abstract
The development of effective vaccines against infectious diseases remains a critical challenge in global health. Animal models play a crucial role in vaccine development by providing valuable insights into the efficacy, safety, and mechanisms of immune response induction, which guide the design and formulation of vaccines. However, traditional animal models often inadequately recapitulate human immune responses. Humanized mice (hu-mice) models with a functional human immune system have emerged as invaluable tools in bridging the translational gap between preclinical research and clinical trials for human vaccine development. This review summarizes commonly used hu-mice models and advances in optimizing them to improve human immune responses. We review the application of humanized mice for human vaccine development with a focus on HIV-1 vaccines. We also discuss the remaining challenges and improvements needed for the currently available hu-mice models to better facilitate the development and testing of human vaccines for infectious diseases.Keywords
Funding Information
- National Key R&D Program (2023YFC2306600, 82071784, 2042022dx0003)
- National Natural Science Foundation of China (2023YFC2306600, 82071784, 2042022dx0003)
- Fundamental Research Funds for the Central Universities (2023YFC2306600, 82071784, 2042022dx0003)
This publication has 122 references indexed in Scilit:
- Poly I:C and STING agonist‐primed DC increase lymphoid tissue polyfunctional HIV‐1‐specific CD8+ T cells and limit CD4+ T‐cell loss in BLT miceEuropean Journal of Immunology, 2021
- Pathogenic Role of Type I Interferons in HIV-Induced Immune Impairments in Humanized MiceCurrent HIV/AIDS Reports, 2019
- Accelerated thymopoiesis and improved T‐cell responses in HLA‐A2/‐DR2 transgenic BRGS‐based human immune system miceEuropean Journal of Immunology, 2019
- Improved B cell development in humanized NOD‐scid IL2Rγnull mice transgenically expressing human stem cell factor, granulocyte‐macrophage colony‐stimulating factor and interleukin‐3Immunity, Inflammation and Disease, 2016
- A novel Flt3‐deficient HIS mouse model with selective enhancement of human DC developmentEuropean Journal of Immunology, 2016
- Human immune system mice: current potential and limitations for translational research on human antibody responsesImmunologic Research, 2011
- Hematopoietic Stem Cell Transplant into Non-Myeloablated W/W v Mice to Detect Steady-State Engraftment Defects2008
- Development of Vaccines and Passive Immunotherapy Against Sars Coronavirus Using Mouse and Scid-PBL/hu Mouse Models2006
- RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangementCell, 1992
- RAG-1-deficient mice have no mature B and T lymphocytesCell, 1992